Shilpa's primary goal is to create cGMP facilities to manufacture Oncology Products that will enable to obtain approvals from EDQM, UK MHRA, TGA Australia, Health Canada and USFDA. By supplying products complying the above regulatory authorities to the pharmaceutical companies worldwide, Shilpa will provide an optimum return on investment to our investors, shareholders and our employees. The common people will also enjoy the highest quality products at an affordable prices.